Table 1.
Study visits and data collection
| Visit 1 Day 0 | Visit 2 Week 2 (Day 14) | Visit 3: final visit Week 12 (Day 84) | |
|---|---|---|---|
| Written informed consent and randomisation (if not done prior to visit 1) and collection of baseline demographics | x | ||
| Resource use (not baseline visit) and information seeking | (x) | x | x |
| Resource satisfaction questionnaire | x | x | |
| Bronchiectasis knowledge questionnaire | x | x | x |
| QOL-B | x | x | x |
| SGRQ | x | x | |
| HADS | x | x | x |
| FIS | x | x | |
| EQ-5D | x | x | x |
| Number of unscheduled visits | x | x | x |
| Exacerbation frequency | x | x | x |
| FEV1 | x (if not done in past 3 months) | x |
QOL-B Quality of Life Questionnaire-Bronchiectasis, SGRQ St. George’s Respiratory Questionnaire, HADS Hospital Anxiety and Depression Scale, FIS Fatigue Impact Scale, EQ-5D Euroqol 5-dimension (quality of life scale), FEV1 forced expiratory volume in 1 second